{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"description":"To identify an appropriate dose of IMO-8400 for further clinical evaluation via evaluation of DLT at each dose level","groups":[{"description":"IMO-8400 0.6 mg/kg once weekly s.c.","id":"OG000","title":"IMO-8400 0.6 mg/kg 1x/wk"},{"description":"IMO-8400 1.2 mg/kg once weekly s.c.","id":"OG001","title":"IMO-8400 1.2 mg/kg 1x/wk"},{"description":"IMO-8400 1.2 mg/kg twice weekly s.c.","id":"OG002","title":"IMO-8400 1.2 mg/kg 2x/wk"},{"description":"IMO-8400 2.4 mg/kg once weekly s.c.","id":"OG003","title":"IMO-8400 2.4 mg/kg 1x/wk"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Safety Population","reportingStatus":"POSTED","timeFrame":"28 days","title":"Identify the Number of Patients Experiencing DLTs at Each Dose Level","type":"SECONDARY","unitOfMeasure":"Participants"}